N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide

C95H72F4N12O4S4 — CID 160933521

IUPACN-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide
SMILESO=C(CCCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(CCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(Cc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1
InChIInChI=1S/C26H18FN3OS.C24H20FN3OS.C23H18FN3OS.C22H16FN3OS/c27-21-11-9-19(10-12-21)22-16-28-26(25(29-22)23-6-3-13-32-23)30-24(31)15-17-7-8-18-4-1-2-5-20(18)14-17;25-19-13-11-18(12-14-19)20-16-26-24(23(27-20)21-9-5-15-30-21)28-22(29)10-4-8-17-6-2-1-3-7-17;24-18-11-9-17(10-12-18)19-15-25-23(22(26-19)20-7-4-14-29-20)27-21(28)13-8-16-5-2-1-3-6-16;23-17-10-8-16(9-11-17)18-14-24-22(21(25-18)19-7-4-12-28-19)26-20(27)13-15-5-2-1-3-6-15/h1-14,16H,15H2,(H,28,30,31);1-3,5-7,9,11-16H,4,8,10H2,(H,26,28,29);1-7,9-12,14-15H,8,13H2,(H,25,27,28);1-12,14H,13H2,(H,24,26,27)
InChIKeySTOPGPAGNHDNMU-UHFFFAOYSA-N
MW1649.96 g/mol
LogP23.09
Rot. Bonds23

About N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide

N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide (PubChem CID 160933521) has the molecular formula C95H72F4N12O4S4 and a molecular weight of 1649.96 g/mol. Its IUPAC name is N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide.

Molecular Properties

Compound NameN-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide
PubChem CID160933521
Molecular FormulaC95H72F4N12O4S4
Molecular Weight1649.96 g/mol
Exact Mass1648.46
IUPAC NameN-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide
SMILESO=C(CCCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(CCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(Cc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1
InChIInChI=1S/C26H18FN3OS.C24H20FN3OS.C23H18FN3OS.C22H16FN3OS/c27-21-11-9-19(10-12-21)22-16-28-26(25(29-22)23-6-3-13-32-23)30-24(31)15-17-7-8-18-4-1-2-5-20(18)14-17;25-19-13-11-18(12-14-19)20-16-26-24(23(27-20)21-9-5-15-30-21)28-22(29)10-4-8-17-6-2-1-3-7-17;24-18-11-9-17(10-12-18)19-15-25-23(22(26-19)20-7-4-14-29-20)27-21(28)13-8-16-5-2-1-3-6-16;23-17-10-8-16(9-11-17)18-14-24-22(21(25-18)19-7-4-12-28-19)26-20(27)13-15-5-2-1-3-6-15/h1-14,16H,15H2,(H,28,30,31);1-3,5-7,9,11-16H,4,8,10H2,(H,26,28,29);1-7,9-12,14-15H,8,13H2,(H,25,27,28);1-12,14H,13H2,(H,24,26,27)
InChIKeySTOPGPAGNHDNMU-UHFFFAOYSA-N
XLogP23.09
TPSA219.52 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds23
Heavy Atoms119
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001649.96
LogP ≤ 523.09
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Analyze N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide
CID 68398188
2,6-difluoro-N-[5-(2-methyl-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl)pyrazin-2-yl]benzamide;bis(2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide);2-fluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]propanamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]propanamide
CID 157387614
2,6-difluoro-N-[5-(2-methyl-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl)pyrazin-2-yl]benzamide;3,5-difluoro-N-[5-(2-methyl-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl)pyrazin-2-yl]pyridine-4-carboxamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-(2-methyl-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl)pyrazin-2-yl]propanamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide
CID 157393582
2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]propanamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]propanamide
CID 157488338
2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[6-(trifluoromethyl)-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]propanamide
CID 158251562
2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]propanamide
CID 158302839
bis(2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide);2-fluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]propanamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]-2-pyridinyl]propanamide
CID 158375381
2,6-difluoro-N-[5-[6-(trifluoromethyl)-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[6-(trifluoromethyl)-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl]-2-pyridinyl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[6-(trifluoromethyl)-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[6-(trifluoromethyl)-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl]-2-pyridinyl]propanamide
CID 158515952
3,5-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]pyridine-4-carboxamide;3,5-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]pyridine-4-carboxamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[6-(trifluoromethyl)-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]propanamide
CID 159183436
2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]propanamide
CID 159270813
(6S)-2-amino-6-(3,5-difluorophenyl)-3,6-dimethyl-5-[5-(trifluoromethyl)-2-pyridinyl]-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-(3-pyridin-4-ylimidazo[1,2-a]pyridin-6-yl)-5H-pyrimidin-4-one;(6S)-2-amino-3,6-dimethyl-6-[3-(3-pyrrolidin-1-ylphenyl)phenyl]-5H-pyrimidin-4-one;3-[5-[(4S,5S)-2-amino-5-ethyl-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]-2-ethylthiophen-3-yl]benzonitrile;3-[5-[(4S,5R)-2-amino-5-ethyl-1,4-dimethyl-6-oxo-5H-pyrimidin-4-yl]-2-ethylthiophen-3-yl]benzonitrile;(6S)-6'-(3-fluorophenyl)-2-methyliminospiro[1,3-diazinane-6,4'-2,3-dihydro-1H-naphthalene]-4-one
CID 159998825
2,6-difluoro-N-[5-[2-(trifluoromethyl)-5,6-dihydro-4H-cyclopenta[b]thiophen-3-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]benzamide;2,6-difluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-fluoro-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[6-(trifluoromethyl)-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl]-2-pyridinyl]benzamide;2-methyl-N-[5-[2-(trifluoromethyl)-4,5,6,7-tetrahydro-1-benzothiophen-3-yl]pyrazin-2-yl]propanamide
CID 161542720

Frequently Asked Questions

What is the IUPAC name of N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide?
The IUPAC name of N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide (CID 160933521) is N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide.
What is the SMILES notation for N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide?
The canonical SMILES for N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide is O=C(CCCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(CCc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(Cc1ccc2ccccc2c1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.O=C(Cc1ccccc1)Nc1ncc(-c2ccc(F)cc2)nc1-c1cccs1.
What is the InChIKey of N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide?
The InChIKey is STOPGPAGNHDNMU-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H18FN3OS.C24H20FN3OS.C23H18FN3OS.C22H16FN3OS/c27-21-11-9-19(10-12-21)22-16-28-26(25(29-22)23-6-3-13-32-23)30-24(31)15-17-7-8-18-4-1-2-5-20(18)14-17;25-19-13-11-18(12-14-19)20-16-26-24(23(27-20)21-9-5-15-30-21)28-22(29)10-4-8-17-6-2-1-3-7-17;24-18-11-9-17(10-12-18)19-15-25-23(22(26-19)20-7-4-14-29-20)27-21(28)13-8-16-5-2-1-3-6-16;23-17-10-8-16(9-11-17)18-14-24-22(21(25-18)19-7-4-12-28-19)26-20(27)13-15-5-2-1-3-6-15/h1-14,16H,15H2,(H,28,30,31);1-3,5-7,9,11-16H,4,8,10H2,(H,26,28,29);1-7,9-12,14-15H,8,13H2,(H,25,27,28);1-12,14H,13H2,(H,24,26,27).
What are the key properties of N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide?
N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide has a molecular weight of 1649.96 g/mol, XLogP of 23.09, 23 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-naphthalen-2-ylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-2-phenylacetamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-4-phenylbutanamide;N-[5-(4-fluorophenyl)-3-thiophen-2-ylpyrazin-2-yl]-3-phenylpropanamide is sourced from PubChem (CID 160933521), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).